Published in J Gen Virol on May 01, 2003
Crimean-Congo hemorrhagic fever in Bulgaria. Emerg Infect Dis (2004) 1.54
Emerging zoonoses and vector-borne infections affecting humans in Europe. Epidemiol Infect (2007) 1.43
An update on crimean congo hemorrhagic Fever. J Glob Infect Dis (2011) 1.34
Crimean-Congo hemorrhagic fever virus: genetic analysis and tick survey in Turkey. J Clin Microbiol (2006) 1.21
Human MxA protein inhibits the replication of Crimean-Congo hemorrhagic fever virus. J Virol (2004) 1.17
Crimean-Congo hemorrhagic fever Asia-2 genotype, Pakistan. Emerg Infect Dis (2013) 1.01
Epidemiology and phylogenetic analysis of crimean-congo hemorrhagic fever viruses in xinjiang, china. J Clin Microbiol (2009) 0.95
Re-emergence of Crimean-Congo hemorrhagic fever virus in Central Africa. PLoS Negl Trop Dis (2011) 0.94
Genetic analysis and epidemiology of Crimean Congo Hemorrhagic fever viruses in Baluchistan province of Pakistan. BMC Infect Dis (2013) 0.80
Serological and Virological Evidence of Crimean-Congo Haemorrhagic Fever Virus Circulation in the Human Population of Borno State, Northeastern Nigeria. PLoS Negl Trop Dis (2016) 0.75
Study of the genetic variability of Crimean-Congo hemorrhagic fever virus in Central Asia. Dokl Biochem Biophys (2004) 0.75
Unilateral deep brain stimulation of the nucleus accumbens in patients with treatment-resistant obsessive-compulsive disorder: Outcomes after one year. Clin Neurol Neurosurg (2009) 2.57
Stimulate or degenerate: deep brain stimulation of the nucleus basalis Meynert in Alzheimer dementia. World Neurosurg (2012) 1.55
Deep brain stimulation of the nucleus accumbens and the internal capsule in therapeutically refractory Tourette-syndrome. J Neurol (2007) 1.33
Cognitive functions in a patient with Parkinson-dementia syndrome undergoing deep brain stimulation. Arch Neurol (2009) 1.15
The neurological presentation of ceruloplasmin gene mutations. Eur Neurol (2008) 1.02
Tourette syndrome deep brain stimulation: a review and updated recommendations. Mov Disord (2014) 1.02
Deep Brain Stimulation and the Search for Identity. Neuroethics (2011) 1.00
Genetic analysis of Crimean-Congo hemorrhagic fever virus in Russia. J Clin Microbiol (2003) 0.97
Molecular epidemiology and interferon susceptibility of the natural recombinant hepatitis C virus strain RF1_2k/1b. J Infect Dis (2008) 0.97
Deep brain stimulation of the nucleus accumbens for the treatment of addiction. Ann N Y Acad Sci (2012) 0.96
Duplication of the common carotid artery and the ipsilateral vertebral artery with a fenestration of the contralateral common carotid artery. Neurol India (2009) 0.95
Extrapyramidal and cerebellar movement disorder in association with heterozygous ceruloplasmin gene mutation. J Neurol (2005) 0.95
Retropharyngeal tendinitis: a rare differential diagnosis of severe headaches and neck pain. Headache (2007) 0.95
Update on the role of antipsychotics in the treatment of Tourette syndrome. Neuropsychiatr Dis Treat (2012) 0.93
Patients' expectations of deep brain stimulation, and subjective perceived outcome related to clinical measures in Parkinson's disease: a mixed-method approach. J Neurol Neurosurg Psychiatry (2013) 0.93
In vivo evidence of deep brain stimulation-induced dopaminergic modulation in Tourette's syndrome. Biol Psychiatry (2011) 0.92
Bithalamical deep brain stimulation in tourette syndrome is associated with reduction in dopaminergic transmission. Biol Psychiatry (2009) 0.90
New neutralizing antibody epitopes in hepatitis C virus envelope glycoproteins are revealed by dissecting peptide recognition profiles. Vaccine (2011) 0.90
The effect of residual fibres on the micro-topography of cellulose nanopaper. Micron (2013) 0.90
Generation of a recombinant cytomegalovirus for expression of a hantavirus glycoprotein. J Virol (2003) 0.90
Pharmacokinetic-pharmacodynamic indices of enrofloxacin in Escherichia coli O78/H12 infected chickens. Food Chem Toxicol (2011) 0.88
Changes in apraxia after deep brain stimulation of the nucleus basalis Meynert in a patient with Parkinson dementia syndrome. Mov Disord (2010) 0.85
Imaging frontotemporal lobar degeneration. Curr Neurol Neurosci Rep (2014) 0.80
The impact of subthalamic deep brain stimulation on caregivers of Parkinson's disease patients: an exploratory study. J Neurol (2014) 0.79
Deep brain stimulation for the treatment of addiction. Addiction (2011) 0.78
Rapid geographical clustering of wound botulism in Germany after subcutaneous and intramuscular injection of heroin. Neurocrit Care (2007) 0.77
Russian science: what the scientists say. Nature (2007) 0.77
Informed consent in deep brain stimulation - ethical considerations in a stress field of pride and prejudice. Front Integr Neurosci (2011) 0.77
Surgery for Tourette syndrome. World Neurosurg (2012) 0.76
Influence of Yersinia pseudotuberculosis on the immunity of echinoderms. Adv Exp Med Biol (2003) 0.76
[Frontotemporal dementia]. Med Klin (Munich) (2007) 0.75
Laser-induced fluorescence of uranyl complexes in aqueous solutions: the role of diffusion-controlled excited states annihilation. Opt Express (2013) 0.75
Is deep brain stimulation a treatment option for addiction? Addiction (2015) 0.75
Micro-structural characterisation of homogeneous and layered MFC nano-composites. Micron (2012) 0.75
Clinical pharmacology in Russia-historical development and current state. Eur J Clin Pharmacol (2014) 0.75
Interference of spin states in photoemission from Sb/Ag(111) surface alloys. J Phys Condens Matter (2011) 0.75
Will deep-brain stimulation be as successful in major depression as it has been in Parkinson's disease? Expert Rev Neurother (2010) 0.75